IMPORTANT DATA

This document presents data from the 2020 Canadian Community Health Survey on the prevalence of Multiple Chemical Sensitivity (MCS) and at least one other chronic condition across Canada, stratified by MCS diagnosis, gender, and age, with results displayed alongside 95% confidence intervals: Demographic characteristics of the MCS population in Canada, 2020

This document presents findings from the 2022 Canadian Community Health Survey (CCHS), which showed a significant decline in reported cases of Multiple Chemical Sensitivity (MCS) compared to 2021. It also outlines possible explanations for this change, including differences in survey methods and question presentation between the two years: Explanation: The data from the 2022 CCHS reported a significant drop in MCS cases compared to the 2021 CCHS

This document presents data from the Canadian Community Health Survey (2005) on the frequency of additional diagnoses among Canadians with Multiple Chemical Sensitivity (MCS), highlighting the chronic conditions most commonly associated with MCS in the general population: Frequency of Associated Diagnosis with Multiple Chemical Sensitivity (MCS)